ArticleBMJ case reports2020

Clinical, pharmacokinetic and economic analysis of the first switch to an extended half-life factor IX (albutrepenonacog alfa, rFIX-FP) in Spain.

Manuel Rodríguez López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.